Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|June 6, 2022
Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II miceHideto Morimoto, Hiroki Morioka, Atsushi Imakiire, et al.International Journal of Molecular Sciences|October 14, 2022
Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in MucopolysaccharidosesKohtaro Minami, Hideto Morimoto, Hiroki Morioka, et al.Molecular and Cellular Biochemistry|August 5, 2020
Upregulated miR-224-5p suppresses osteoblast differentiation by increasing the expression of Pai-1 in the lumbar spine of a rat model of congenital kyphoscoliosisSho Ishiwata, Haku Iizuka, Hiroyuki Sonoda, et al.European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|August 9, 2023
Calcium sensing and signaling are impaired in the lumbar spine of a rat model of congenital kyphosisItsuki Takahashi, Yusuke Watanabe, Hiroyuki Sonoda, et al.Journal of Cellular Biochemistry|May 7, 2019
The retinol-retinoic acid metabolic pathway is impaired in the lumbar spine of a rat model of congenital kyphoscoliosisHiroyuki Sonoda, Haku Iizuka, Sho Ishiwata, et al.Molecular Genetics and Metabolism Reports|November 3, 2022
Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzymeAndreas Hahn, Yuji Sato, Toshiaki Ikeda, et al.Pharmaceutics|June 24, 2022
Treatment of Neuronopathic Mucopolysaccharidoses with Blood-Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated TranscytosisHiroyuki Sonoda, Kenichi Takahashi, Kohtaro Minami, et al.JIMD Reports|November 12, 2021
Divergent developmental trajectories in two siblings with neuropathic mucopolysaccharidosis type II (Hunter syndrome) receiving conventional and novel enzyme replacement therapies: A case reportKazuyoshi Tomita, Shungo Okamoto, Toshiyuki Seto, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 1, 2019
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 TrialTorayuki Okuyama, Yoshikatsu Eto, Norio Sakai, et al.Case Reports in Orthopedics|August 31, 2019
Intradural Extramedullary Spinal Sarcoidosis Mimicking MeningiomaSho Ishiwata, Yoichi Iizuka, Tokue Mieda, et al.Pageof 4